16.10.2013 Views

Role of the Pharmacist in Preventing Distribution of Counterfeit ... - FIP

Role of the Pharmacist in Preventing Distribution of Counterfeit ... - FIP

Role of the Pharmacist in Preventing Distribution of Counterfeit ... - FIP

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Prevent<strong>in</strong>g <strong>Distribution</strong> <strong>of</strong> <strong>Counterfeit</strong> Medications (pr<strong>in</strong>ter-friendly)<br />

Many <strong>of</strong> <strong>the</strong>se anticounterfeit<strong>in</strong>g technologies are be<strong>in</strong>g used by pharmaceutical companies to ensure<br />

distribution <strong>of</strong> <strong>the</strong> au<strong>the</strong>ntic product from <strong>the</strong> manufactur<strong>in</strong>g site to <strong>the</strong> pharmacy. When <strong>the</strong>se technologies are<br />

widely used for pharmaceutical packages, pharmacists will be able to quickly au<strong>the</strong>nticate <strong>the</strong> unique<br />

identification number to determ<strong>in</strong>e whe<strong>the</strong>r <strong>the</strong> number is genu<strong>in</strong>e and <strong>the</strong> product is legitimate. The Institute for<br />

Safe Medication Practices reports that pharmacies us<strong>in</strong>g imag<strong>in</strong>g and/or scann<strong>in</strong>g technologies as part <strong>of</strong> <strong>the</strong><br />

prescription verification process make fewer medication errors and recommends adoption <strong>of</strong> a standardized<br />

prescription verification process <strong>in</strong> all pharmacies. [24] Use <strong>of</strong> imag<strong>in</strong>g and/or scann<strong>in</strong>g technologies coupled with<br />

s<strong>of</strong>tware that pr<strong>in</strong>ts a description <strong>of</strong> <strong>the</strong> medication's appearance on <strong>the</strong> pharmacy label or receipt also would<br />

reduce <strong>the</strong> chances <strong>of</strong> dispens<strong>in</strong>g a counterfeit medication.<br />

On-dosage Form Technologies<br />

FDA provides guidance to pharmaceutical manufacturers on <strong>the</strong> use <strong>of</strong> physical–chemical identifiers (PCIDs) <strong>in</strong><br />

solid oral dosage forms. [25] A PCID is "a substance or comb<strong>in</strong>ation <strong>of</strong> substances possess<strong>in</strong>g unique physical or<br />

chemical properties that unequivocally identifies and au<strong>the</strong>nticates a drug product <strong>of</strong> dosage form." [25] Examples<br />

<strong>in</strong>clude <strong>in</strong>ks, flavors, and chemical tags that are detectable analytically us<strong>in</strong>g techniques such as <strong>in</strong>frared,<br />

ultraviolet, and fluorescence detectors or visually us<strong>in</strong>g magnification. [25]<br />

Importance <strong>of</strong> Education<br />

<strong>Pharmacist</strong>s, technicians, student pharmacists, and patients need to be educated about counterfeit medications.<br />

Pr<strong>of</strong>essional materials are available from <strong>the</strong> Partnership for Safe Medic<strong>in</strong>es. [26–28] Additional practical tips for<br />

identify<strong>in</strong>g and prevent<strong>in</strong>g distribution <strong>of</strong> counterfeit medications are available from <strong>the</strong> World Health<br />

Organization, [7] <strong>the</strong> Royal Society <strong>of</strong> Great Brita<strong>in</strong>, [29] and <strong>the</strong> International Pharmaceutical Federation. [30]<br />

Report<strong>in</strong>g Suspicious Medications to Ensure Future Integrity<br />

<strong>Pharmacist</strong>s should report suspect counterfeit medications through Medwatch. [31] Some pharmaceutical<br />

companies will send an <strong>in</strong>vestigator to a pharmacy to exam<strong>in</strong>e suspicious products and conduct au<strong>the</strong>ntication<br />

tests if requested. Suspicious products should be removed from <strong>the</strong> dispens<strong>in</strong>g area immediately until fur<strong>the</strong>r<br />

<strong>in</strong>struction is given from FDA or o<strong>the</strong>r law enforcement <strong>of</strong>ficials.<br />

Conclusion<br />

<strong>Pharmacist</strong>s play a critical role <strong>in</strong> prevent<strong>in</strong>g <strong>the</strong> distribution <strong>of</strong> counterfeit medications. By rais<strong>in</strong>g awareness,<br />

identify<strong>in</strong>g education materials with practical suggestions, and implement<strong>in</strong>g recommendations to ensure <strong>the</strong><br />

<strong>in</strong>tegrity <strong>of</strong> <strong>the</strong> supply cha<strong>in</strong>, pharmacists can help address <strong>the</strong> threat <strong>of</strong> counterfeit medications.<br />

Sidebar<br />

At a Glance<br />

Page 4 <strong>of</strong> 6<br />

Synopsis: To help combat <strong>the</strong> threat <strong>of</strong> counterfeit medications, an American <strong>Pharmacist</strong>s Association<br />

taskforce recommends that pharmacists purchase medications from known, reliable sources, warn patients <strong>of</strong><br />

<strong>the</strong> dangers <strong>of</strong> purchas<strong>in</strong>g medications over <strong>the</strong> Internet, determ<strong>in</strong>e whe<strong>the</strong>r distributors purchased <strong>the</strong> product<br />

from <strong>the</strong> manufacturer or ano<strong>the</strong>r reliable source, and monitor counterfeit product alerts.<br />

Analysis: The issue <strong>of</strong> packag<strong>in</strong>g and dosage form au<strong>the</strong>ntication systems is complicated by <strong>the</strong> fact that<br />

detection technology must be simple to use and cost effective <strong>in</strong> <strong>the</strong> field but unable to be easily thwarted by<br />

counterfeiters. The White House's <strong>Counterfeit</strong> Pharmaceutical Inter-Agency Work<strong>in</strong>g Group has recommended<br />

that Congress adopt a track-and-trace system for pharmaceuticals and related products, and <strong>the</strong> Food and Drug<br />

Adm<strong>in</strong>istration has issued guidance on us<strong>in</strong>g standardized numeric identifiers to create a unique "license plate"<br />

to track <strong>in</strong>dividual drug packages <strong>in</strong> <strong>the</strong> supply cha<strong>in</strong>. The Institute for Safe Medication Practices recommends<br />

adoption <strong>of</strong> a standardized prescription verification process <strong>in</strong> all pharmacies and has reported that pharmacies<br />

us<strong>in</strong>g imag<strong>in</strong>g and/or scann<strong>in</strong>g technologies as part <strong>of</strong> <strong>the</strong> prescription verification process make fewer<br />

medication errors.<br />

http://www.medscape.com/viewarticle/759122_pr<strong>in</strong>t<br />

14.3.2012

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!